This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

2 Jan 2014

Epigenetic?s Researcher?s Enthuse Over ChromaTrap ChIP Technology

Porvair Sciences reports strong growing demand for their Chromatrap chromatin immunoprecipitation (ChIP) assay technology from academic groups and biopharmaceutical organisations involved with epigenetic research.


Stephen Knight, Sales and Marketing Director commented: "An expanding number of proven application solutions and the introduction of the Chromatrap 96 HT solid-state ChIP high throughput platform has enabled us to more than double the number of research groups using ChromaTrap assay technology during the last 12 months."  He added: "We are particularly pleased by the very positive feedback from early adopters of the technology."


Brian J. Engel, a Biochemistry & Cell Biology researcher at Rice University, USA commented: "What I like most about the Chromatrap kit compared with traditional bead-based ChIP assays is the ease of use, speed and reliability. There is no worry about accidentally losing beads during washes and reducing output chromatin when using the column-based method." His colleague, Curt Warren, added: "We have found that the Chromatrap kit is quick, reliable and flexible. Saving reagents and time with this kit makes it easier and more feasible to conduct more thorough and effective IP-based experiments. With the enhanced reproducibility using Chromatrap, I would not go back to bead-based ChIP and the assay has been fully endorsed and adopted within our research team."


Professor Steve Conlan, Head of Molecular & Cell Biology at Swansea University, UK commented: "Chromatrap streamlines the complicated experimental procedure associated with chromatin-IP making it a much quicker and user-friendly assay compared with conventional bead based assays. Using this kit we obtain much more consistent data, and most importantly can use much less input sample. We have made a permanent switch to using Chromatrap for all our cell line and primary cell based assays, and fully endorse the technology." Research assistant, Dr Helen Whiteland, added: "What I like about the Chromatrap assay is the ease of use and quick method allowing me to analyse my data in the same day."

Related News